Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Pietrzak RH et al. |
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. |
2014 |
Neuropsychopharmacology |
pmid:24820537
|
Scotchie JG et al. |
Endocannabinoid regulation in human endometrium across the menstrual cycle. |
2015 |
Reprod Sci |
pmid:24819878
|
|
|
|
|
pmid:24813296
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Park SW et al. |
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species. |
2015 |
Head Neck |
pmid:24797795
|
|
|
|
|
pmid:24788457
|
Hama AT et al. |
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain. |
2014 |
PLoS ONE |
pmid:24788435
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
|
|
|
|
pmid:24747871
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
|
|
|
|
pmid:24717329
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
|
|
|
|
pmid:24705535
|
Kaczocha M et al. |
Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. |
2014 |
PLoS ONE |
pmid:24705380
|
Sun LJ et al. |
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. |
2014 |
Int. J. Infect. Dis. |
pmid:24704332
|
Jackson AR et al. |
Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. |
2014 |
PLoS ONE |
pmid:24699635
|
|
|
|
|
pmid:24687644
|
Baranowska-Kuczko M et al. |
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24682422
|
|
|
|
|
pmid:24674601
|
|
|
|
|
pmid:24671517
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Basavarajappa BS et al. |
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. |
2014 |
Hippocampus |
pmid:24648181
|
Yu S et al. |
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain. |
2014 |
J. Biol. Chem. |
pmid:24644281
|
Engeli S et al. |
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. |
2014 |
Obesity (Silver Spring) |
pmid:24616451
|
Gamage TF et al. |
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. |
2014 |
Behav Pharmacol |
pmid:24603340
|
Kwilasz AJ et al. |
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. |
2014 |
Behav Pharmacol |
pmid:24583930
|
Chianese R et al. |
Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis. |
2014 |
Gen. Comp. Endocrinol. |
pmid:24566122
|
Okura D et al. |
The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes. |
2014 |
Anesth. Analg. |
pmid:24557103
|
Sanson B et al. |
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. |
2014 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:24531463
|
Chiou LC et al. |
Targeting the cannabinoid system for pain relief? |
2013 |
Acta Anaesthesiol Taiwan |
pmid:24529672
|
Pava MJ et al. |
Endocannabinoid modulation of cortical up-states and NREM sleep. |
2014 |
PLoS ONE |
pmid:24520411
|
Rapino C et al. |
Endocannabinoids as biomarkers of human reproduction. |
2014 Jul-Aug |
Hum. Reprod. Update |
pmid:24516083
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
|
|
|
|
pmid:24508153
|
Rea K et al. |
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. |
2014 |
Eur. J. Neurosci. |
pmid:24494683
|
Sousa-Valente J et al. |
Anandamide in primary sensory neurons: too much of a good thing? |
2014 |
Eur. J. Neurosci. |
pmid:24494681
|
Sagie S et al. |
[Short-and long-term effects of cannabinoids on memory, cognition and mental illness]. |
2013 |
Harefuah |
pmid:24483000
|
Al Kury LT et al. |
Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. |
2014 |
Cell Calcium |
pmid:24472666
|
Björklund E et al. |
Ketoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrations. |
2014 |
PLoS ONE |
pmid:24466356
|
Kono M et al. |
Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors. |
2014 |
Bioorg. Med. Chem. |
pmid:24440478
|
|
|
|
|
pmid:24438603
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Krishnan G and Chatterjee N |
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity. |
2014 |
Mol. Cell. Neurosci. |
pmid:24418364
|
Leo LM et al. |
Age-dependent relevance of endogenous 5-lipoxygenase derivatives in anxiety-like behavior in mice. |
2014 |
PLoS ONE |
pmid:24416334
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Mahavadi S et al. |
Inhibitory signaling by CB1 receptors in smooth muscle mediated by GRK5/β-arrestin activation of ERK1/2 and Src kinase. |
2014 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:24407588
|
Fowler CJ |
Has FLAT fallen flat? |
2014 |
Trends Pharmacol. Sci. |
pmid:24398120
|
Carr RL et al. |
Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition. |
2014 |
Neurotoxicology |
pmid:24373905
|
Gesell FK et al. |
Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder. |
2013 |
BMC Vet. Res. |
pmid:24370333
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Luce V et al. |
The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide. |
2014 |
Regul. Pept. |
pmid:24342802
|
Bystrowska B et al. |
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. |
2014 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:24334211
|
Gunduz-Cinar O et al. |
Amygdala FAAH and anandamide: mediating protection and recovery from stress. |
2013 |
Trends Pharmacol. Sci. |
pmid:24325918
|
Vavilin VA et al. |
Cytochrome P450 4F2 polymorphism in patients with liver cirrhosis. |
2013 |
Bull. Exp. Biol. Med. |
pmid:24319743
|
Jackson AR et al. |
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. |
2014 |
J. Leukoc. Biol. |
pmid:24319288
|
Martinez-Vargas M et al. |
Does the neuroprotective role of anandamide display diurnal variations? |
2013 |
Int J Mol Sci |
pmid:24287910
|
Hoyer FF et al. |
Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice. |
2014 |
J. Mol. Cell. Cardiol. |
pmid:24286707
|
Schaefer C et al. |
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. |
2014 |
Eur Arch Psychiatry Clin Neurosci |
pmid:24253425
|
Harvey BS et al. |
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. |
2014 |
Cytokine |
pmid:24238999
|
Leung K et al. |
Role of FAAH-like anandamide transporter in anandamide inactivation. |
2013 |
PLoS ONE |
pmid:24223930
|
Battista N et al. |
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24218186
|
Liu J et al. |
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24191036
|
Wenzel D et al. |
Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24167249
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Burston JJ and Woodhams SG |
Endocannabinoid system and pain: an introduction. |
2014 |
Proc Nutr Soc |
pmid:24148358
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Stanley CP et al. |
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes. |
2013 |
Eur. J. Pharmacol. |
pmid:24120371
|
Marichal-Cancino BA et al. |
Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. |
2014 |
Basic Clin. Pharmacol. Toxicol. |
pmid:24118786
|
Bernabò N et al. |
Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol. |
2013 |
OMICS |
pmid:24117401
|
|
|
|
|
pmid:24117326
|
|
|
|
|
pmid:24114173
|
Malenczyk K et al. |
CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release. |
2013 |
J. Biol. Chem. |
pmid:24089517
|
Alvheim AR et al. |
Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. |
2014 |
Lipids |
pmid:24081493
|
Marichal-Cancino BA et al. |
Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats. |
2013 |
Eur. J. Pharmacol. |
pmid:24076186
|
Fonseca BM et al. |
The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation. |
2013 |
Apoptosis |
pmid:24048885
|
Limebeer CL et al. |
Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system. |
2014 |
Psychopharmacology (Berl.) |
pmid:24043345
|
Adinolfi B et al. |
Anticancer activity of anandamide in human cutaneous melanoma cells. |
2013 |
Eur. J. Pharmacol. |
pmid:24041928
|
|
|
|
|
pmid:24037493
|
Hill MN et al. |
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. |
2013 |
Psychoneuroendocrinology |
pmid:24035186
|
Akerman S et al. |
Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. |
2013 |
J. Neurosci. |
pmid:24027286
|
Brocato B et al. |
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. |
2013 |
Placenta |
pmid:24008071
|
O'Brien LD et al. |
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus). |
2013 |
Br. J. Pharmacol. |
pmid:23991698
|
Gervasi MG et al. |
Anandamide levels fluctuate in the bovine oviduct during the oestrous cycle. |
2013 |
PLoS ONE |
pmid:23977311
|
Jourdan T et al. |
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. |
2013 |
Nat. Med. |
pmid:23955712
|
Piomelli D |
More surprises lying ahead. The endocannabinoids keep us guessing. |
2014 |
Neuropharmacology |
pmid:23954677
|
|
|
|
|
pmid:23948212
|
Krumbholz A et al. |
Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair. |
2013 |
Ther Drug Monit |
pmid:23942543
|
Derbenev AV and Smith BN |
Dexamethasone rapidly increases GABA release in the dorsal motor nucleus of the vagus via retrograde messenger-mediated enhancement of TRPV1 activity. |
2013 |
PLoS ONE |
pmid:23936221
|
Maione S et al. |
Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. |
2013 |
Pharmacol. Res. |
pmid:23911581
|
Khlaifia A et al. |
Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. |
2013 |
J. Neurosci. |
pmid:23904599
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Lisboa SF et al. |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. |
2013 |
Neuropharmacology |
pmid:23899460
|
Coppola M and Mondola R |
Palmitoylethanolamide: from endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence. |
2013 |
Med. Hypotheses |
pmid:23896215
|
Ruginsk SG et al. |
Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion. |
2013 |
Clin. Exp. Pharmacol. Physiol. |
pmid:23875874
|
Citraro R et al. |
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. |
2013 |
Epilepsy Res. |
pmid:23860329
|
Iannotti FA et al. |
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. |
2013 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:23830028
|
Silvestri C et al. |
Anandamide-derived prostamide F2α negatively regulates adipogenesis. |
2013 |
J. Biol. Chem. |
pmid:23801328
|
Brantl SA et al. |
Mechanism of platelet activation induced by endocannabinoids in blood and plasma. |
2014 |
Platelets |
pmid:23789792
|
Carr RL et al. |
Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure. |
2013 |
Toxicol. Sci. |
pmid:23761300
|